Michele Vigolo
4PUBLICATIONS
35CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Sep 15, 2023
A Phase I Study of the Pan-Notch Inhibitor CB-103 for Patients with Advanced Adenoid Cystic Carcinoma and Other Tumors.Glenn J Hanna, Anastasios Stathis, Elena Lopez-Miranda
|Aug 12, 2023
The Efficacy of CB-103, a First-in-Class Transcriptional Notch Inhibitor, in Preclinical Models of Breast Cancer.Michele Vigolo, Charlotte Urech, Sebastien Lamy
|Aug 05, 2021
Targeting Notch Inhibitors to the Myeloma Bone Marrow Niche Decreases Tumor Growth and Bone Destruction without Gut Toxicity.Hayley M Sabol, Adam J Ferrari, Manish Adhikari
|Jul 01, 2020
Pharmacological disruption of the Notch transcription factor complex.Rajwinder Lehal, Jelena Zaric, Michele Vigolo
Pageof 1
Frequent Collaborators
1 joint publications
Jelena Zaric
1 joint publications
Charlotte Urech
1 joint publications
Nadine Zangger
1 joint publications
Linlin Cao
1 joint publications
Adeline Berger
1 joint publications
Sylvain Loubéry
1 joint publications
Ute Koch
1 joint publications
Jon C Aster
1 joint publications
Jovanny Zabaleta
1 joint publications
Luis Del Valle
